Clinical Trials

63 results for Prostate Cancer


UpFrontPSMA : A Randomised Phase 2 Study of Sequential 177Lu-PSMA617 and Docetaxel Versus Docetaxel in Metastatic Hormone-Naive Prostate Cancer

  • Condition: Metastatic Hormone Naive Prostate Cancer
  • Study ID: NCT04343885
View Trial

A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and Non-African American Men With Prostate Cancer (VANDAAM Study)

  • Condition: Prostate Cancer
  • Intervention: Other: Decipher® Testing
  • Study ID: NCT02723734
View Trial

A Multicenter, Open-Label, Exploratory Platform Study to Evaluate Biomarkers and Immunotherapy Combinations for the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

  • Condition: Metastatic Castration-resistant Prostate Cancer
  • Intervention: Drug: NKTR-214 (Cohort A), Drug: Nivolumab (Cohort A and B), Radiation: Stereotactic body radiation therapy (SBRT) (Cohort B), Drug: CDX-301 (Cohort B), Drug: poly-ICLC (Cohort B)
  • Study ID: NCT03835533
View Trial

A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1

  • Condition: Prostate Cancer
  • Intervention: Drug: DKN-01 300 mg, Drug: DKN-01 600 mg, Drug: Docetaxel 75 mg/m2, Drug: DKN-01 150 mg
  • Study ID: NCT03837353
View Trial

Early Detection of Prostate Cancer by Liquid Biopsy

  • Condition: Prostate Cancer
  • Study ID: NCT04556916
View Trial

A Phase 1, Open-label Study in Two Parts, Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of CCW702 in Patients With Metastatic, Castration Resistant Prostate Adenocarcinoma

  • Condition: Castration-Resistant Prostatic Cancer
  • Intervention: Drug: CCW702
  • Study ID: NCT04077021
View Trial

  • Condition: Prostate Cancer
  • Study ID: NCT04390880
View Trial

VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent

  • Condition: Metastatic Castration-resistant Prostate Cancer, Androgen Resistant Prostatic Cancer
  • Study ID: NCT04844749
View Trial

A Phase II Multi-Center Trial of Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

  • Condition: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
  • Study ID: NCT04751929
View Trial

Local Cytoreductive Treatments for Men With Newly Diagnosed Metastatic Prostate Cancer in Addition to Standard of Care Treatment

  • Condition: Prostate Cancer, Metastatic Prostate Cancer
  • Intervention: Combination Product: Standard of Care, Procedure: Minimally Invasive Ablative Therapy (MIAT), Procedure: Radical Therapy (Prostatectomy or Radiotherapy)
  • Study ID: NCT03763253
View Trial

A Phase II Clinical Study of SHR3680 Combined With Docetaxel in the Treatment of Metastatic Castration-resistant Prostate Cancer Previously Treated With Abiraterone

  • Condition: Prostate Cancer Metastatic
  • Study ID: NCT04603833
View Trial

A Phase IIA Study of Sequential ("First Strike, Second Strike") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for High Risk Metastatic Castration Sensitive Prostate Cancer

  • Condition: Prostate Cancer, Stage IV Prostate Cancer
  • Study ID: NCT05189457
View Trial

Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancer

  • Condition: Prostate Cancer
  • Study ID: NCT04886986
View Trial